TY - JOUR AU - Temesgen, Z. AU - Feinberg, J. PY - 2007 DA - 2007// TI - Tipranavir: A New Option for the Treatment of Drug-Resistant HIV Infection JO - Clin Infect Dis VL - 45 UR - https://doi.org/10.1086/520847 DO - 10.1086/520847 ID - Temesgen2007 ER - TY - JOUR AU - Markowitz, M. AU - Slater, L. N. AU - Schwartz, R. PY - 2007 DA - 2007// TI - Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens JO - J Acquir Immune Defic Syndr VL - 45 UR - https://doi.org/10.1097/QAI.0b013e318074eff5 DO - 10.1097/QAI.0b013e318074eff5 ID - Markowitz2007 ER - TY - JOUR AU - Hicks, C. B. AU - Cahn, P. AU - Cooper, D. A. PY - 2006 DA - 2006// TI - Durable efficacy of tipranavir-ritonavir in combination with an optimized background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multidrug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomized open-label trials JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69154-X DO - 10.1016/S0140-6736(06)69154-X ID - Hicks2006 ER - TY - JOUR AU - Johnson, V. A. AU - Brun-Vezinet, F. AU - Clotet, B. PY - 2008 DA - 2008// TI - Update of the drug resistance mutations in HIV-1: spring 2008 JO - Top HIV Med VL - 16 ID - Johnson2008 ER - TY - CHAP PY - 2008 DA - 2008// BT - Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents ID - ref5 ER - TY - JOUR AU - Chang, S. Y. AU - Chen, M. Y. AU - Lee, C. N. PY - 2008 DA - 2008// TI - Trend of antiretroviral drug resistance in treatment-naïve patients with HIV-1 infection in Taiwan JO - J Antimicrob Chemother VL - 61 UR - https://doi.org/10.1093/jac/dkn002 DO - 10.1093/jac/dkn002 ID - Chang2008 ER - TY - JOUR AU - Baxter, J. D. AU - Schapiro, J. M. AU - Boucher, C. A. PY - 2006 DA - 2006// TI - Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir JO - J Virol VL - 80 UR - https://doi.org/10.1128/JVI.00712-06 DO - 10.1128/JVI.00712-06 ID - Baxter2006 ER - TY - CHAP AU - Borght, K. V. a. n. d. e. r. AU - Winters, B. AU - Van Craenenbroeck, E. PY - 2007 DA - 2007// TI - Correlation of resistance algorithms for tipranavir susceptibility with response to tipranavir containing regimens in the RESIST trials BT - Program and abstracts of the 5th European HIV Drug Resistance Workshop ID - Borght2007 ER - TY - CHAP AU - Bacheler, L. AU - Vermeiren, H. AU - Winters, B. PY - 2006 DA - 2006// TI - Clinically relevant phenotypic resistance and cross-resistance to tipranavir among recent routine clinical isolates BT - Program and abstracts of the 4th European HIV Drug Resistance Workshop ID - Bacheler2006 ER - TY - CHAP AU - Villacian, J. AU - van Craenenbroeck, E. AU - Winters, B. AU - Bacheler, L. PY - 2007 DA - 2007// TI - Phenotypic cut-off values for the clinical interpretation of predicted viral fold change for antiretroviral agents: the vircoTYPE HIV-1 approach BT - Presented at the 4th AS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia, 22-25 July ID - Villacian2007 ER - TY - JOUR AU - Kempf, D. AU - Brun, S. AU - Rode, R. PY - 2000 DA - 2000// TI - Identification of clinically relevant phenotypic and genotypic breakpoints for ABT-378/r in multiple PI-experienced, NNRTI-naive patients JO - Antiviral Ther VL - 5 ID - Kempf2000 ER - TY - JOUR AU - Taylor, B. S. AU - Sobieszczyk, M. E. AU - McCutchan, F. E. AU - Hammer, S. M. PY - 2008 DA - 2008// TI - The Challenge of HIV-1 Subtype Diversity JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMra0706737 DO - 10.1056/NEJMra0706737 ID - Taylor2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/154/prepub UR - http://www.biomedcentral.com/1471-2334/9/154/prepub ID - ref13 ER -